On Wednesday, Addus HomeCare got an upgrade for its IBD SmartSelect Composite Rating from 91 to 96.
Looking For The Best Stocks To Buy And Watch? Start Here
The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. The best stocks tend to have a 95 or better grade as they start a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Addus HomeCare is not currently near a proper buy point. Look for the stock to form and break out of a new base.
The stock has an 88 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 88% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company posted a 17% rise in earnings for Q1. Sales growth increased 20%, up from 8% in the prior report. The company has now posted rising growth in each of the last two quarters.
Addus HomeCare holds the No. 3 rank among its peers in the Medical-Outpatient/Home Care industry group. BrightSpring Hlth Svcs is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
